Bupa plans long-term stay in India, targets top three position
This article was originally published in Clinica
Max Bupa, as the JV has been named, plans to offer health insurance across the whole of India, and will begin by rolling out the service on a "region by region basis". The company sees the mostly untapped market as a good opportunity and is undaunted by the potential future competition. "India is such a potentially large insurance market that it has room for different offerings that can allow a range of organisations to succeed," said Mr Mochrie.
You may also be interested in...
Three upcoming medical device regulations were discussed at BSI’s Hong Kong Forum in April that will be important to the success of Hong Kong’s voluntary regulatory system, the Medical Device Administrative Control System.
Saudi Arabia has adopted an interim marketing authorisation regulation under which, possibly as early as 2010, only medical devices that have been approved by the Saudi Arabia Food and Drug Administration will be allowed on the market1. Additionally, only medical devices that comply with the regulations in force in the European Union, the US, Canada, Japan or Australia – ie in the jurisdiction of a Global Harmonization Task Force founding member - will be eligible for marketing in the country2,3.
The government of Canada has launched a marketing campaign to encourage consumers and healthcare professionals to use the country’s MedEffect initiative for reporting suspected adverse events related to healthcare products1.